P.A.W. Capital Corp Q2 Portfolio Changes: Focus on Financials and Tech
In its latest filing dated June 30, 2026, P.A.W. Capital Corp disclosed significant changes to its portfolio holdings.
Insider database analysis reveals notable shifts in the investment strategy of P.A.W. Capital Corp during Q2 2026, as evidenced by their latest filing dated June 30th.
The firm demonstrated a clear focus on large-cap technology companies and healthcare/pharmaceutical firms in this quarter's activity. Among the top performers showing significant buying interest are several major corporations within Financial Services and Healthcare sectors.
P.A.W.'s Significant New Positions
- P.A.W. Capital Corp significantly increased its stake in several large-cap Financial Services firms, including Morgan Stanley (MS), Merck Co Inc New (MRK), JPMorgan Chase Co (JPM), Johnson & Johnson (JNJ), and Ares Capital Corp (ARCC).
- These substantial purchases represent new positions or significant boosts to existing ones for these highly weighted stocks.
Their Technology investments also saw notable additions, particularly Commerce.com Inc (BIGC) which received a considerable increase in holdings. This suggests confidence in the sector's prospects despite other recent tech exits.
Recent Acquisitions and Portfolio Boosts
- P.A.W.'s portfolio percentage allocation for P.A.W. Capital Corp's largest holdings saw significant boosts this quarter.
- For instance, the stake in Pfizer Inc (PFE) increased by 100%, adding substantially to its Healthcare allocation.
- The position in Bristol Myers SQUIBB Co (BMY), another key healthcare stock, also grew by a full 100% during this period.
Additionally, the firm bolstered its Communication Services sector exposure through new purchases of shares in Magnite Inc (MGNI) and Verizon Communications (VZ).